Adenovirus-mediated transfer of cyclin-dependent kinase inhibitor-p21 suppresses neointimal formation in the balloon-injured rat carotid arteries in vivo

Annals of the New York Academy of Sciences

Volumn 811, Issue , 1997, Pages 401-411

  Ueno, Hikaru ^a,b   Masuda, Satoko ^a   Nishio, Shoko ^a   Li, Juan Jun ^a   Yamamoto, Hiroaki ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; PROTEIN P21;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; CAROTID ARTERY DISEASE; CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL MIGRATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; IMMUNOBLOTTING; MALE; NONHUMAN; RAT; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; ANIMALIA;

EID: 0030750148     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52020.x     Document Type: Conference Paper

References (34)

1. SERRUYS, P. W., H. E. LUIJTEN, K. J. BEAT, R. GEUSKENS, P. J. DE FEYTER, B. VAN DEN BRAND, C. RJH, TEN KATEN, A. vEG & P. G. HUGENHOLTZ. 1988. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 77: 361-371.
2. ROSS, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
3. LANDAU, C., R. A. LANGE & L. D. HILLIS. 1994. Percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 330: 981-993.
4. KASTAN, M. B., Q. ZHAN, W. S. EL-DEIRY, F. CARRIER, T. JACKS, W. V. WALSH, B. S. PLUNKETT, B. VOGELSTEIN & A. J. FORNACE, JR. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-teleangiectasia. Cell 71: 587-597.
5. KUERBITZ, S. J., B. S. PLUNKETT, W. V. WALSH & M. B. KASTAN. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89: 7491-7495.
6. FIELDS, S. & S. K. JANG. 1990. Presence of a potent transcription activating sequence in the p53 protein. Science 249: 1045-1049.
7. RAYCROFT, L., H. WU & G. LOZANO. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249: 1049-1051.
8. KERN, S. E., K. W. KINZLER, A. BRUSKIN, D. JAROSZ, P. FRIEDMAN, C. PRIVES & B. VOGELSTEIN. 1991. Identification of p53 as a sequence specific DNA binding protein. Science 252: 1707-1711.
9. FUNK, W. D., D. T. PAK, R. H. KARAS, W. E. WRIGHT & J. W. SHAY. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12: 2866-2871.
10. ZAMBETTI, G. P., J. K. W. BARGONETTI, C. PRIVES & A. J. LEVINE. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev. 6: 1143-1152.
11. EL-DEIRY, W. S., T. TORINO, V. E. VELCULESCU, D. B. LEVY, R. PARSONS, J. M. TRENT, D. LIN, W. E. MERCER, K. W. KINZLER & B. VEGELSTEIN. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
12. HARPER, J. W., G. R. ADAMI, N. WEI, K. KEYOMARSI & S. J. ELLEDGE. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
13. NODA, A., T. NING & S. F. VENABLE. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
14. XIONG, Y., H. ZHANG & D. BEACH. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505-514.
15. XIONG, Y., G. J. HANNON, H. ZHANG, D. CASSO, R. KOBAYASHI & D. BEACH. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
16. HARPER, J. W., S. J. ELLEDGE, K. KEYOMARSI, B. DYNLACHT, L-H. TSAI, P. ZHANG, S. DOBROWOLSKI, C. BAI, L. CONNELL-CROWLEY, E. SWINDELL, M. P. FOX & N. WEI. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6: 387-400.
17. UENO, H., J-J. LI, H. TOMITA, H. YAMAMOTO, Y. PAN, Y. KANEGAE, I. SAITO & A. TAKESHITA. 1995. Quantitative analysis of repeated adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscl. Thromb. Vasc. Biol. 15: 2246-2253.
18. MIYAKE, S., M. MAKIMURA, Y. KANEGAE, S. HARADA, Y. SATO, K. TAKAMORI, C. TOKUDA & I. SAITO. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 93: 1320-1324.
19. LI, J-J., H. UENO, Y. PAN, H. TOMITA, H. YAMAMOTO, Y. KANEGAE, I. SAITO & A. TAKESHITA. 1995. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc. Res. 30: 97-105.
20. LI, J-J., H. UENO, H. TOMITA, H. YAMAMOTO, Y. KANEGAE, I. SAITO & A. TAKESHITA. 1995. Adenovirus-mediated arterial gene transfer does not require prior injury for submaximal gene expression. Gene Ther. 2: 351-354.
21. MCMURRAY, H. F., D. P. PARROT & D. E. BOWYER. 1991. A standard method of culturing aortic explants, suitable for the study of factors affecting the phenotypic modulation, migration and proliferation of aortic smooth muscle cells. Atherosclerosis 86: 227-237.
22. SIMONS, M., E. R. EDELMAN, J-L. DEKEYSER, R. LANGER & R. D. ROSENBERG. 1992. Antisense c-myb oligonucleotides inhibit intimai arterial smooth muscle cell accumulation in vivo. Nature 359: 67-70.
23. SHI, Y., A. FARD, A. GALEO, H. G. HUTCHINSON, P. VERMANI, G. R. DODGE, D. J. HALL, F. SHAHEEN & A. ZALEWSKI. 1994. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation 90: 944-951.
24. MORISHITA, R., G. H. GIBBONS, K. E. ELLISON, M. NAKAJIMA, L. ZHANG, Y. KANEDA, T. OGIHARA & V. J. DZAU. 1993. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA 90: 8474-8478.
25. CHANG, M. W., E. BARR, J. SELTZER, Y-Q. JIANG, G. J. NABEL, E. G. NABEL, M. S. PARMACEK & J. M. LEIDEN. 1995. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267: 518-522.
26. GUYTON, J. R., R. D. ROSENBERG, A. W. CLOWES & M. J. KARNOVSKY. 1980. Inhibition of rat arterial smooth muscle cell proliferation by heparin. Circ. Res. 46: 625-634.
27. OHNO, T., D. GORDON, H. SAN, V. J. POMPILI, M. J. IMPERIALE, G. J. NABEL & E. G. NABEL. 1994. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265: 781-784.
28. GUZMAN, R. J., P. LEMARCHAND, R. G. CRYSTAL, S. E. EPSTEIN & T. FINKEL. 1993. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation 88: 2838-2848.
29. LEE, S. W., B. C. TRAPNELL, J. J. RADE, R. VIRMANI & D. A. DICHEK. 1993. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ. Res. 73: 797-807.
30. HALEVY, O., B. G. NOVITCH, D. B. SPICER, S. X. SKAPEK, J. RHEE, G. J. HANNON, D. BEACH & A. B. LASSAR. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
31. PARKER, S. B., G. EICHELE, P. ZHANG, A. RAWLS, A. T. SANDS, A. BRADLEY, E. N. OLSEN, J. W. HARPER & S. J. ELLEDGE. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
32. SERRANO, M., G. J. HANNON & D. BEACH. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
33. SKAPEK, S. X., J. RHEE, D. B. SPICER & A. B. LASSAR. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022-1024.
34. INDOLFI, C., E. V. AVVEDIMENTO, A. RAPACCIUOLO, E. DI LORENZO, G. ESPOSITO, E. STABILE, A. FELICIELLO, E. MELE, P. GIULIANO, G. CONDORELLI & M. CHIARIELLO. 1995. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1: 541-545.